Journal of Virology, March 2001, p. 2345-2352, Vol. 75, No. 5
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2345-2352.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
ek1,
andOncology Center1 and Department of Molecular Biology and Genetics,2 The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231
Received 28 April 2000/Accepted 29 November 2000
Human herpesvirus 8 (HHV-8; Kaposi's sarcoma herpesvirus) encodes
four open reading frames with homology to cellular proteins of
interferon regulatory factor (IRF) family. Three of them, viral IRF-1
(vIRF-1), vIRF-2, and vIRF-3, have been cloned and found, when
overexpressed, to down-regulate the transcriptional activity of
interferon type I gene promoters in infected cells by interfering with
the transactivating activity of cellular IRFs. In this study, we have
further characterized vIRF-2 and shown that it is a nuclear protein
which is constitutively expressed in HHV-8-positive pleural effusion
lymphoma cell lines. Nuclear localization of vIRF-2 was confirmed by in
situ detection of ectopically expressed enhanced green fluorescent
protein/vIRF-2 fusion protein. We found that the expression of vIRF-2
in HEK293 cells inhibited the antiviral effect of interferon and
rescued translation of vesicular stomatitis virus mRNA from
interferon-induced translational block. To provide insight into the
mechanism of this effect we have demonstrated that vIRF-2 physically
interacts with PKR consequently inhibiting autophosphorylation of
double-stranded RNA-activated protein kinase (PKR) and blocking
phosphorylation of PKR substrates histone 2A and eukaryotic translation
initiation factor 2
. These results suggest that the latently
expressed vIRF-2 has a role in viral mimicry which targets the activity
of interferon-induced PKR kinase. By inhibiting the kinase activity of
PKR and consequent down-modulation of protein synthesis, HHV-8 has
evolved a mechanism by which it can overcome the interferon-mediated
antiviral effect. Thus, the anti-interferon functions of vIRF-2 may
contribute to the establishment of a chronic or latent infection.
Present address: Department of Pharmacology of Natural Products and
Clinical Pharmacology, University of Ulm, Ulm, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|